# EDARAVONE
> **ANDA218349** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2024-03-13
## Drug
- **FDA Application Number:** ANDA218349
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EDARAVONE
- **Generic name:** Edaravone
- **Active ingredients:** EDARAVONE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ZYDUS PHARMS USA INC
- **First approval:** 2024-03-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218349)
---
*MORVS · CC0 1.0*